openPR Logo
Press release

Companion Diagnostics Market-Applications And Market Trends

06-23-2017 11:52 AM CET | Health & Medicine

Press release from: Market Data Forecast

We Think Through Different Layers, We Work Across Different Verticals

We Think Through Different Layers, We Work Across Different Verticals

According to the report Global Companion Diagnostics Market published by Market Data Forecast, the global market is projected to reach USD 8.88 billion by 2021, at a CAGR of 21.6% from 2016 to 2021.

View report at: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640

The Global Companion Diagnostics market is recognized to be as a growing need of tailored medications and modified cancer treatment, increasing adoption of companion diagnostic tests by end users such as biotechnology and pharmaceutical, firms and reference laboratories, and encouragement by regulatory bodies such as EMA and FDA to implement developments of companion diagnostic test at the initial phases of drug development techniques.

Download free sample at: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/request-sample

Companion diagnostics is a relatively new branch of diagnostics that is expected to grow at a fast pace in coming days as well as increased its market demand globally. The applications of Companion diagnostic are to regulate patient personal molecular profile in supporting to determine which therapy will work for the patient. This diagnostic procedure needs a biopsied matter or a tissue to contact the appearance of biomarker protein or mutant. Companion diagnostics are also used in defining Companion biomarker, which helps foresee response of toxicity.

Request discount at: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/request-discount

The factors influencing the Global Market for Companion Diagnostics Market, either positively or negatively are presented in the DROC analysis. Some of the things discussed in the section are asking adoption of companion diagnostic tests, encouragement from regulatory bodies and emerging advanced technologies such as next-generation sequencing (NGS). To seizure this market, pharmaceutical companies are motivated to enter into the global market through strategic achievements and alliances with NGS platform diagnostic firms

For granular level understanding, the Companion Diagnostics Marketis segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.

Inquire before buying: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/inquire

By Indications:
Oncology
•Colorectal Cancer
•Breast Cancer
•Lung Cancer
•Gastric Cancer
•Melanoma
Inflammation and Autoimmune Diseases
Cardiovascular Diseases
Central Nervous System Disorders
Virology Diseases

By Technology:
Immuno Histochemistry
Molecular Diagnostics
•In-Situ Hybridization
•Real Time PCR
•Gene Sequencing

Buy now: https://www.marketdataforecast.com/cart/buy-now/global-companion-diagnostics-market-640

Based on geography the market is analyzed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle East. Due to technical advancement and huge investment on research & development, North America is leading the companion diagnostic market. While Europe and Asia-Pacific are expected to grow at significant growth rate.

North America Companion Diagnostics Market
Europe Companion Diagnostics Market
Asia-Pacific Companion Diagnostics Market
Latin America Companion Diagnostics Market
Middle-East and Africa Companion Diagnostics Market

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Bio systems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

The Companion Diagnostics Market study offers the following deliverables:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming

•Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail

•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

•Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses

•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment

•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market-Applications And Market Trends here

News-ID: 593782 • Views:

More Releases from Market Data Forecast

Smart Homes Market Size, Share, Growth Report 2024-2029
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period. Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and
Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the middle east steel rebar market was worth US$ 8.59 billion in 2023 and is anticipated to reach a valuation of US$ 13.19 billion by 2029 and it is predicted to register a CAGR of 7.4% during the forecast period 2024-2029. the Middle East is driving strong demand for steel rebar, the backbone of reinforced concrete. This growth is fueled
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & Forecast Report 2024-2029.
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & F …
According to the latest research report published by Market Data Forecast, the middle east and africa industrial lubricants market was worth US$ 18.51 billion in 2023 and is anticipated to reach a valuation of US$ 22.62 billion by 2029 and it is predicted to register a CAGR of 3.4% during the forecast period 2024-2029. Industrial lubricants in the Middle East and Africa are specialized substances vital for reducing friction and wear
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2029.
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029. Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion